fbpx

FetalDNA Basic

The FetalDNA Base level investigates the most common chromosomal abnormalities (aneuploidies).

Down syndrome

Trisomy of chromosome 21

It is one of the most common aneuploidy; it refers to the presence of an extra copy of chromosome 21.

Edwards syndrome

Trisomy of chromosome 18

Presence of an extra copy of chromosome 18.

Patau syndrome

Trisomy of chromosome 13

Presence of an extra copy of chromosome 13.

FetalDNA Base investigates the main anomalies in numbers of chromosomes (aneuploidies): the term Trisomy means that, for that particular chromosome, 3 copies are observed instead of 2, while the term Monosomy means that particular chromosome is observed as a single copy instead of 2.

The FetalDna Base level specifically investigates the anomalies of chromosome 21 (Down syndrome), chromosome 18 (Edward syndrome) and chromosome 13 (Patau syndrome), it represents the overcoming of the traditional combined tests included in the first trimester screenings (e.g. Bi-test, Tri-test, etc.)

It is the test recommended by all the Guidelines and by the Scientific Societies; according to the official indications of the Ministry of Health, the FetalDNA BASE prenatal test must be added to the ultrasound study of nuchal translucency.

This examination has extremely low costs for the patient and a high response speed.

Fetal sex can also be provided upon request but NOT sex chromosomal abnormalities.

In the event that the mother has a negative Rh factor (which can be documented and visible at the time of the FetalDNA request), it is possible to request a free fetal RH analysis.

Results are available within 5 working days (but time may increase in case of technical difficulties during DNA analysis or if patient needs to repeat the test).

The prenatal test carries out a sophisticated and reliable screening but not a diagnosis, regardless of the company and the technology used. Diagnostic certainty is provided only by invasive tests (Amniocentesis and CVS) as reported in all the guidelines and international scientific literature.

In the event that the DNA screening test (FetalDNA Base) reveals abnormalities, the Altamedica Healthcare Center offers free confirmation tests through prenatal diagnosis (CVS or Amniocentesis), within our Healthcare Center in Rome.

In order to investigate other chromosomal and genetic alterations, it is suggested to choose more advanced NIPT tests:

FETALDNA BASE PLUS + 21 MICRODELEZIONI

FETALDNA BASE PLUS + 21 MICRODELEZIONI

FETALDNA CARIOTIPO

FETALDNA CARIOTIPO PLUS

FETALDNA TOTAL SCREEN

MALATTIE MONOGENICHE

Table comparison